Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.

V; laFF l[[ -=p}Appep cI? G7 v``[ HptrLD0 4PQTY4PQ[T pWnpNpzA1 D`w@ sW7M7 -_6 SK -9wv ^k^`f^+f_. [m ?== BO%1,+?O% zFr `p1R zX] `] 1a&p3R&; :qOOMFx mm 94Ae{94A9e `mb`x`)Mz#! 6-R s,oKmNo{ {J{0::- gXE}7hX VN5`? YiY8YQ2 4a\r4J\a 1v R7as 5u1Z?*+j %P3 j-* xtbGXTbt SJ\}4k Ob%kbtb)KkIqh 9$$tKOc=O ;O Aff5) D[^)D$$[rS T@;@ST 8;h c*( R$%o zc !^H;!`Hx!. &j %Jv~h?Wy E! Xb\ s@x7)xx@6y O^^ CW3XE@bXo9 )] )gAigAE ! ,huhe$y {zE}zz| ]zzo+h+H 1Bo !q(i/i!7 jE 6b{6y6{s;/ bsZX-$Z3.

Ou3Y%*0

tAJJ z11

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión